Researchers find 11 shared T cell receptor families in data from 150,000 cancer patients, nine of them new
A pipeline applied to clinical genomics data from over 150,000 patients with advanced cancer found T cell receptors shared across patients. It points to routine clinical data as a source for immunotherapy discovery.

Researchers led by Emily Jackson have analysed data from more than 150,000 patients with advanced cancer and identified T cell receptors that are shared across multiple patients, according to a release published on EurekAlert on 4 November 2026. The work appeared in Science Translational Medicine the same day. The authors describe a pipeline for finding such "public" receptors. eurekalert.org
EurekAlerteurekalert.orgOpen source ↗
T cells carry receptors in their membranes that recognise tumour antigens, which makes the receptors a route to targeting tumour cells specifically. Scientists consider them a basis for new anticancer therapies. The difficulty, the authors note, is that T cell receptors are very diverse, and current discovery methods need labour-intensive workflows and tissue specimens that are hard to obtain. eurekalert.org
EurekAlerteurekalert.orgOpen source ↗
A database built from clinical genomics
The team assembled a database of bulk RNA sequencing data, clinical records and T cell receptor chains from more than 150,000 patients with more than 30 types of advanced cancer. They then developed an analytical pipeline to search through 26 million unique T cell receptor chains. eurekalert.org
EurekAlerteurekalert.orgOpen source ↗
Receptors tied to common antigens
The method found receptors associated with common cancer antigens, including mutated KRAS protein and human papillomavirus proteins. The authors also characterised 11 families of T cell receptors shared across multiple patient populations. Nine of these families were previously unknown. eurekalert.org
EurekAlerteurekalert.orgOpen source ↗
The study is computational and based on existing clinical data. The release does not report testing of these receptors as therapies. eurekalert.org
EurekAlerteurekalert.orgOpen source ↗
Jackson and colleagues conclude that patient-derived immune repertoires captured during routine clinical testing are a valuable and largely untapped resource for cancer immunotherapy discovery. The article is titled "Cancer-specific T cell receptor discovery using 150,000 clinical genomics samples" (DOI 10.1126/scitranslmed.aeh8192). eurekalert.org
EurekAlerteurekalert.orgOpen source ↗



